An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A company called PlexusDx posted a short item linking Melanotan II and sexual health with a specific genetic variant called MC1R rs1805008. In plain terms, they’re saying there’s an interaction between a synthetic tanning peptide (Melanotan II) and a gene variant that affects the melanocortin 1 receptor (MC1R), and that this might relate to how people respond to the peptide. The post is a brief genetic “insight” rather than a full scientific study. Melanotan II is a lab-made peptide originally developed to darken skin by activating the body’s pigment-making system. It’s not an approved prescription drug for tanning; people sometimes buy and inject it off-label. Beyond tanning, Melanotan II can also activate other related receptors that influence sexual arousal and blood pressure, which is why occasional users report increased libido or spontaneous erections. The MC1R gene makes a receptor best known for controlling skin color and freckling, but genetic differences in MC1R have been linked to varying responses to melanocortin-related compounds. What PlexusDx seems to be doing is highlighting one specific genetic change, rs1805008, and suggesting it’s relevant to how someone might respond to Melanotan II. The post reads like a genetic note for consumers: if you carry that variant, your experience with the peptide may differ. The item is not a controlled clinical trial. From the snippet alone, there’s no data on how many people were observed, how big the effect is, or whether any formal study was done. So this is more an informational pointer than proof that the gene causes a predictable change in sexual side effects. Why this matters: people experimenting with Melanotan II often report sexual side effects, so a genetic clue could help explain why reactions vary between individuals. If accurate, the insight could be useful for people trying to anticipate side effects or for clinicians answering questions about off-label peptide use. It’s also of interest to anyone curious about how genetics can influence drug and supplement responses — the general idea that your DNA can affect how you react to a chemical is real and increasingly useful. Important caveats: PlexusDx’s note is not the same as a peer-reviewed study. Melanotan II is not regulated for tanning or sexual enhancement, and its safety profile isn’t well established. Reported side effects include nausea, flushing, increased blood pressure, and changes in skin pigmentation; there are also concerns about injection-site sterility and long-term risks. Genetic associations can be subtle and depend on other genes and environment; carrying rs1805008 does not guarantee any particular reaction. Anyone considering Melanotan II should be cautious, talk to a healthcare professional, and be skeptical of genetic “insights” that lack published evidence. Bottom line: PlexusDx flagged a possible link between a tanning peptide and a specific skin-color gene variant that might influence sexual side effects, but the note is preliminary and not proof — treat it as an interesting lead, not a prescription.
Source: PlexusDx